Unum Group’s headline result for Q3 2026 was a net loss of $419.7 million, but that figure is almost entirely explained by a single deliberate accounting consequence: an $853 million investment loss, primarily related to impairment losses on assets intended for transfer in the Fortitude Re long-term care reinsurance transaction. Strip that out, and the picture underneath is more instructive, and more troubling in one specific area.
After-tax adjusted operating income fell to $349 million for the quarter, down 27.2% from $479.4 million a year earlier. CEO Richard McKenney said in the release that “underlying earnings results did fall short of our expectations,” pointing to “elevated claim submissions in group disability” as the reason.
Unum’s group disability benefit ratio in Q3 2026 was 67.1%. At the start of 2026, Unum guided to a full-year group disability benefit ratio of 62% to 64%. In Q1 it came in at 63.7%, already above the midpoint. In Q2 it rose to 65.8%, exceeding the top of the guided range, driven primarily by elevated short-term disability claims in states with newer paid family and medical leave (PFML) programs.
The Q3 announcement cites a different and more significant driver: higher incidence, prior period pricing actions, and higher average claim size in the long-term disability product line.
The first two quarters of pressure were concentrated in short-term disability and PFML. Those were the lines where claims are transient and repricing can move relatively quickly. Long-term disability claims carry longer tails and larger reserve implications. The shift in the driver across quarters does not confirm a reserve problem, but it changes the nature of the question that brokers renewing group disability coverage need to be asking.
Group disability adjusted operating income fell 60.4% year-over-year to $94.8 million, from $239.3 million in Q3 2025. Unum’s US group disability sales also declined 8.5% in the quarter. Unum has been implementing double-digit price increases on new PFML business since Q2, but those take time to flow through renewals, and the Q3 numbers suggest the repricing has not yet caught up with the claims.
Colonial Life, which distributes voluntary benefits through the workplace, delivered its strongest quarter of the year. Adjusted operating income rose 35.0% to $169.4 million, and its benefit ratio fell to 38.0% from 46.3% a year earlier, driven by favorable reserve assumption updates and strong claims experience in cancer, critical illness, and life products. Sales grew 6.4%.
The two results reflect a structural difference in claims risk. Voluntary products are shaped by the employer’s workforce characteristics and participation rates. In core group disability, the statutory expansion of leave mandates has introduced claims volumes that the initial pricing did not anticipate. As of August 2026, 16 US jurisdictions had enacted PFML programs, with more states in the pipeline, and each new state represents another round of pricing uncertainty until experience data matures.
Unum’s full-year adjusted operating income per share guidance was revised to $8.30 to $8.50. Premium income across core operations grew 4.7% on a constant currency basis, and the company repurchased $202 million in shares and paid $80.1 million in common stock dividends in the quarter. Capital levels remain robust, with a weighted average risk-based capital ratio of approximately 485%.
